Use the collections feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#1
REVIEW
Vi Nguyen, Jacob George
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of abnormalities that can range from bland liver fat (steatosis), to hepatic inflammation and liver injury (steatohepatitis). It is estimated that NAFLD will become the principal cause of liver disease in Western nations and the leading indication for liver transplantation. Advancements in disease recognition and management are therefore paramount. Although the development of new, reliable drug therapies is vital, lifestyle interventions remain the most effective treatment modality...
August 2015: Seminars in Liver Disease
#2
REVIEW
Mitra K Nadim, Francois Durand, John A Kellum, Josh Levitsky, Jacqueline G O'Leary, Constantine J Karvellas, Jasmohan S Bajaj, Andrew Davenport, Rajiv Jalan, Paolo Angeli, Stephen H Caldwell, Javier Fernández, Claire Francoz, Guadalupe Garcia-Tsao, Pere Ginès, Michael G Ison, David J Kramer, Ravindra L Mehta, Richard Moreau, David Mulligan, Jody C Olson, Elizabeth A Pomfret, Marco Senzolo, Randolph H Steadman, Ram M Subramanian, Jean-Louis Vincent, Yuri S Genyk
No abstract text is available yet for this article.
March 2016: Journal of Hepatology
1
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
